R J BIO-TECH | TRANSCHEM | R J BIO-TECH/ TRANSCHEM |
|||
---|---|---|---|---|---|
P/E (TTM) | x | - | 16.3 | - | View Chart |
P/BV | x | - | 0.8 | - | View Chart |
Dividend Yield | % | 0.0 | 0.0 | - |
R J BIO-TECH TRANSCHEM |
EQUITY SHARE DATA | |||||
---|---|---|---|---|---|
R J BIO-TECH Mar-22 |
TRANSCHEM Mar-23 |
R J BIO-TECH/ TRANSCHEM |
5-Yr Chart Click to enlarge
|
||
High | Rs | 12 | 38 | 31.4% | |
Low | Rs | 5 | 16 | 32.5% | |
Sales per share (Unadj.) | Rs | 14.7 | 0 | - | |
Earnings per share (Unadj.) | Rs | -4.3 | 1.0 | -423.1% | |
Cash flow per share (Unadj.) | Rs | -4.2 | 1.0 | -413.4% | |
Dividends per share (Unadj.) | Rs | 0 | 0 | - | |
Avg Dividend yield | % | 0 | 0 | - | |
Book value per share (Unadj.) | Rs | -53.2 | 53.8 | -98.8% | |
Shares outstanding (eoy) | m | 9.47 | 12.24 | 77.4% | |
Bonus / Rights / Conversions | 0 | 0 | - | ||
Price / Sales ratio | x | 0.6 | 0 | - | |
Avg P/E ratio | x | -2.0 | 26.6 | -7.5% | |
P/CF ratio (eoy) | x | -2.0 | 26.4 | -7.7% | |
Price / Book Value ratio | x | -0.2 | 0.5 | -32.1% | |
Dividend payout | % | 0 | 0 | - | |
Avg Mkt Cap | Rs m | 81 | 329 | 24.6% | |
No. of employees | `000 | NA | NA | - | |
Total wages/salary | Rs m | 6 | 8 | 75.7% | |
Avg. sales/employee | Rs Th | 0 | 0 | - | |
Avg. wages/employee | Rs Th | 0 | 0 | - | |
Avg. net profit/employee | Rs Th | 0 | 0 | - |
INCOME DATA | |||||
---|---|---|---|---|---|
Net Sales | Rs m | 139 | 0 | - | |
Other income | Rs m | 7 | 42 | 15.9% | |
Total revenues | Rs m | 146 | 42 | 343.3% | |
Gross profit | Rs m | 12 | -17 | -67.3% | |
Depreciation | Rs m | 1 | 0 | 837.5% | |
Interest | Rs m | 58 | 0 | 582,200.0% | |
Profit before tax | Rs m | -40 | 25 | -161.7% | |
Minority Interest | Rs m | 0 | 0 | - | |
Prior Period Items | Rs m | 0 | 0 | - | |
Extraordinary Inc (Exp) | Rs m | 0 | 0 | - | |
Tax | Rs m | 0 | 13 | 0.0% | |
Profit after tax | Rs m | -40 | 12 | -327.3% | |
Gross profit margin | % | 8.4 | 0 | - | |
Effective tax rate | % | 0 | 50.6 | -0.0% | |
Net profit margin | % | -29.1 | 0 | - |
BALANCE SHEET DATA | |||||
---|---|---|---|---|---|
Current assets | Rs m | 3 | 579 | 0.5% | |
Current liabilities | Rs m | 484 | 1 | 53,725.6% | |
Net working cap to sales | % | -345.9 | 0 | - | |
Current ratio | x | 0 | 643.4 | 0.0% | |
Inventory Days | Days | 3 | 0 | - | |
Debtors Days | Days | 7,265,677 | 0 | - | |
Net fixed assets | Rs m | 16 | 83 | 19.6% | |
Share capital | Rs m | 95 | 122 | 77.4% | |
"Free" reserves | Rs m | -598 | 536 | -111.6% | |
Net worth | Rs m | -503 | 658 | -76.5% | |
Long term debt | Rs m | 33 | 0 | - | |
Total assets | Rs m | 19 | 662 | 2.9% | |
Interest coverage | x | 0.3 | 2,505.0 | 0.0% | |
Debt to equity ratio | x | -0.1 | 0 | - | |
Sales to assets ratio | x | 7.2 | 0 | - | |
Return on assets | % | 92.4 | 1.9 | 4,942.8% | |
Return on equity | % | 8.0 | 1.9 | 428.1% | |
Return on capital | % | -3.8 | 3.8 | -99.1% | |
Exports to sales | % | 0 | 0 | - | |
Imports to sales | % | 2.5 | 0 | - | |
Exports (fob) | Rs m | NA | NA | - | |
Imports (cif) | Rs m | 4 | NA | - | |
Fx inflow | Rs m | 0 | 0 | - | |
Fx outflow | Rs m | 4 | 0 | - | |
Net fx | Rs m | -4 | 0 | - |
CASH FLOW | |||||
---|---|---|---|---|---|
From Operations | Rs m | -47 | 12 | -387.0% | |
From Investments | Rs m | NA | -9 | -0.0% | |
From Financial Activity | Rs m | 47 | NA | - | |
Net Cashflow | Rs m | 0 | 3 | -14.0% |
Indian Promoters | % | 60.3 | 51.7 | 116.7% | |
Foreign collaborators | % | 0.0 | 0.0 | - | |
Indian inst/Mut Fund | % | 0.0 | 0.0 | - | |
FIIs | % | 0.0 | 0.0 | - | |
ADR/GDR | % | 0.0 | 0.0 | - | |
Free float | % | 39.7 | 48.3 | 82.1% | |
Shareholders | 245 | 13,813 | 1.8% | ||
Pledged promoter(s) holding | % | 0.0 | 0.0 | - |
Compare R J BIO-TECH With: KAVERI SEED VENKYS
No comparison is complete without understanding how the stock prices have performed over a period of time.
Here's a brief comparison:
Period | R J BIO-TECH | TRANSCHEM | S&P BSE FMCG |
---|---|---|---|
1-Day | 0.59% | -1.72% | 0.11% |
1-Month | 1.48% | 52.34% | 1.53% |
1-Year | -26.39% | 98.31% | 14.09% |
3-Year CAGR | -24.59% | 22.71% | 15.86% |
5-Year CAGR | -25.99% | 16.44% | 10.81% |
* Compound Annual Growth Rate
Here are more details on the R J BIO-TECH share price and the TRANSCHEM share price.
Moving on to shareholding structures...
The promoters of R J BIO-TECH hold a 60.3% stake in the company. In case of TRANSCHEM the stake stands at 51.7%.
To review how promoter stakes have changed over time, and how much of the promoter stake is pledged, please see the shareholding pattern of R J BIO-TECH and the shareholding pattern of TRANSCHEM.
Finally, a word on dividends...
In the most recent financial year, R J BIO-TECH paid a dividend of Rs 0.0 per share. This amounted to a Dividend Payout ratio of -0.0%.
TRANSCHEM paid Rs 0.0, and its dividend payout ratio stood at 0.0%.
You may visit here to review the dividend history of R J BIO-TECH, and the dividend history of TRANSCHEM.
For a sector overview, read our fmcg sector report.
After opening the day on positive note, Indian share markets continued the momentum as the session progressed and ended on firm footing.